🆕
www.nordicpharma.com
15/08/2026
SEVER Life Sciences B.V. Signs Agreement to Sell Nordic Group B.V. to Alfasigma S.p.A. - Nordic Pharma
Hoofddorp, The Netherlands / Bologna, Italy, 11th August 2026 SEVER Life Sciences B.V. (“SEVER”) today announced that it has signed a Share Purchase Agreement (“SPA”) for the sale of 100% of the shares in Nordic Group B.V. and its subsidiaries (“Nord